High-flow oxygen reduces 90-day mortality, compared with standard oxygen or non-invasive ventilation, in patients with acute hypoxaemic respiratory failure [commentary]

Affiliations

Free article

Comment

Amanda J Piper. J Physiother. 2015 Oct.

Free article

. 2015 Oct;61(4):222.

doi: 10.1016/j.jphys.2015.07.004. Epub 2015 Sep 9.

¹ Department of Respiratory and Sleep Medicine, Royal Prince Alfred Hospital, Sydney, Australia.

No abstract available

Comment on

High-flow oxygen through nasal cannula in acute hypoxemic respiratory failure.
Frat JP, Thille AW, Mercat A, Girault C, Ragot S, Perbet S, Prat G, Boulain T, Morawiec E, Cottereau A, Devaquet J, Nseir S, Razazi K, Mira JP, Argaud L, Chakarian JC, Ricard JD, Wittebole X, Chevalier S, Herbland A, Fartoukh M, Constantin JM, Tonnelier JM, Pierrot M, Mathonnet A, Béduneau G, Delétage-Métreau C, Richard JC, Brochard L, Robert R; FLORALI Study Group; REVA Network. Frat JP, et al. N Engl J Med. 2015 Jun 4;372(23):2185-96. doi: 10.1056/NEJMoa1503326. Epub 2015 May 17. N Engl J Med. 2015. PMID: 25981908 Clinical Trial.
High-flow oxygen reduces 90-day mortality, compared with standard oxygen or non-invasive ventilation, in patients with acute hypoxaemic respiratory failure [synopsis].
Skinner EH. Skinner EH. J Physiother. 2015 Oct;61(4):222. doi: 10.1016/j.jphys.2015.07.002. Epub 2015 Aug 28. J Physiother. 2015. PMID: 26320839 No abstract available.